GLOMERULAR DISEASE

Clinical trials for GLOMERULAR DISEASE explained in plain language.

Never miss a new study

Get alerted when new GLOMERULAR DISEASE trials appear

Sign up with your email to follow new studies for GLOMERULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 3

New pill aims to slow kidney disease in IgA nephropathy patients

Disease control Not yet recruiting

This study tests a new drug, HS-10542, in 90 adults with IgA nephropathy, a kidney disease. The goal is to see if it can lower protein in the urine, a sign of kidney damage. Participants will take either the drug or a placebo for a set period, and researchers will monitor safety …

Matched conditions: GLOMERULAR DISEASE

Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 11, 2026 20:47 UTC

GLOMERULAR DISEASE

Get alerted when new GLOMERULAR DISEASE trials appear

New pill aims to slow kidney disease in IgA nephropathy patients